⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14327439 | 0.78 | — | — | |
| SCHEMBL14639961 | 0.69 | — | — | |
| SCHEMBL17020155 | 0.67 | — | — | |
| SCHEMBL27310855 | 0.67 | — | — | |
| SCHEMBL9276566 | 0.67 | — | — | |
| SCHEMBL18338951 | 0.67 | — | — | |
| SCHEMBL19151075 | 0.65 | — | — | |
| SCHEMBL11815373 | 0.65 | — | — | |
| SCHEMBL28147415 | 0.62 | — | — | |
| SCHEMBL16900488 | 0.62 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170027168-A1 | METHODS, PRODUCTS, AND SYSTEMS RELATING TO MAKING, PROVIDING, AND USING NANOCRYSTALLINE (NC) PRODUCTS COMPRISING NANOCRYSTALLINE CELLULOSE (NCC), NANOCRYSTALLINE (NC) POLYMERS AND/OR NANOCRYSTALLINE (NC) PLASTICS OR OTHER NANOCRYSTALS OF CELLULOSE COMPOSITES OR STRUCTURES, IN COMBINATION WITH OTHER MATERIALS | HEATH STEPHAN (US) | 2017-02-02 | — | — | US | disclosed |
| EP-1296714-B1 | Combination of CpG and antibodies directed against CD19,CD20, CD22 or CD40 for the treatment or prevention of cancer. | UNIV IOWA RES FOUND (US) | 2009-08-26 | — | — | EP | disclosed |
| US-20090155212-A1 | Immunostimulatory nucleic acids and cancer medicament combination therapy for the treatment of cancer | BRATZLER ROBERT L | 2009-06-18 | — | — | US | disclosed |
| US-7534772-B2 | Methods for enhancing antibody-induced cell lysis and treating cancer | UNIVERSITY OF IOWA RESEARCH FOUNDATION (US) | 2009-05-19 | — | — | US | disclosed |
| US-20060211639-A1 | Immunostimulatory nucleic acids and cancer medicament combination therapy for the treatment of cancer | PFIZER INC. | 2006-09-21 | — | — | US | disclosed |
| WO-2006076387-A2 | CYANIDIN-3-GLUCOSIDE AS AN ANTI-NEOPLASTIC AGENT | THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES, CENTERS FOR DISEASE CONTROL AND PREVENTION (US) | 2006-07-20 | — | — | WO | disclosed |
| EP-1296714-A2 | METHODS FOR ENHANCING ANTIBODY-INDUCED CELL LYSIS AND TREATING CANCER | UNIVERSITY OF IOWA RESEARCH FOUNDATION (US) | 2003-04-02 | — | — | EP | disclosed |
| US-20030026801-A1 | Methods for enhancing antibody-induced cell lysis and treating cancer | PFIZER INC. | 2003-02-06 | — | — | US | disclosed |
| US-20020156033-A1 | Immunostimulatory nucleic acids and cancer medicament combination therapy for the treatment of cancer | COLEY PHARMACEUTICAL GROUP, INC. | 2002-10-24 | — | — | US | disclosed |
| WO-2001097843-A2 | METHODS FOR ENHANCING ANTIBODY-INDUCED CELL LYSIS AND TREATING CANCER | UNIVERSITY OF IOWA RESEARCH FOUNDATION (US) | 2001-12-27 | — | — | WO | disclosed |
| EP-0198949-B1 | A PROCES AND INSTALLATION FOR DESTROYING HAZARDOUS WASTES | Shultz, Clifford G. (US) | 1990-07-11 | — | — | EP | disclosed |
| EP-0198949-A1 | A proces and installation for destroying hazardous wastes | Shultz, Clifford G. (US) | 1986-10-29 | — | — | EP | disclosed |